Khalabazyane B, Mizzi C, Rashid R, Adesunloro L, Salah R, Kadhmawi I
Cureus. 2024; 16(6):e61907.
PMID: 38975495
PMC: 11227894.
DOI: 10.7759/cureus.61907.
Abudoubari S, Bu K, Mei Y, Maimaitiyiming A, An H, Tao N
Front Oncol. 2023; 13:1142976.
PMID: 37901326
PMC: 10603232.
DOI: 10.3389/fonc.2023.1142976.
Weng X, Tan W, Wei B, Yang S, Gu C, Wang S
BMC Geriatr. 2023; 23(1):537.
PMID: 37670257
PMC: 10478225.
DOI: 10.1186/s12877-023-04151-2.
Ozah E, Imasogie D
J West Afr Coll Surg. 2023; 13(3):91-95.
PMID: 37538216
PMC: 10395850.
DOI: 10.4103/jwas.jwas_32_23.
Chen D, Niu Y, Chen H, Liu D, Guo R, Yao N
Front Oncol. 2022; 12:994296.
PMID: 36387123
PMC: 9641235.
DOI: 10.3389/fonc.2022.994296.
Screening for Prostate Cancer.
Carlsson S, Vickers A
Med Clin North Am. 2020; 104(6):1051-1062.
PMID: 33099450
PMC: 8287565.
DOI: 10.1016/j.mcna.2020.08.007.
Zonal regulation of collagen-type proteins and posttranslational modifications in prostatic benign and cancer tissues by imaging mass spectrometry.
Angel P, Spruill L, Jefferson M, Bethard J, Ball L, Hughes-Halbert C
Prostate. 2020; 80(13):1071-1086.
PMID: 32687633
PMC: 7857723.
DOI: 10.1002/pros.24031.
Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review.
McNally C, Ruddock M, Moore T, McKenna D
Cancer Manag Res. 2020; 12:5225-5241.
PMID: 32669872
PMC: 7335899.
DOI: 10.2147/CMAR.S250829.
A review of optimal prostate biopsy: indications and techniques.
Streicher J, Meyerson B, Karivedu V, Sidana A
Ther Adv Urol. 2019; 11:1756287219870074.
PMID: 31489033
PMC: 6713958.
DOI: 10.1177/1756287219870074.
Decision models for distinguishing between clinically insignificant and significant tumors in prostate cancer biopsies: an application of Bayes' Theorem to reduce costs and improve outcomes.
Swersey A, Colberg J, Evans R, Kattan M, Ledolter J, Parker R
Health Care Manag Sci. 2019; 23(1):102-116.
PMID: 30880374
DOI: 10.1007/s10729-019-09480-6.
Prostate cancer and subsequent nutritional outcomes: the role of diagnosis and treatment.
Slade A
J Cancer Surviv. 2019; 13(2):171-179.
PMID: 30734156
DOI: 10.1007/s11764-019-00739-z.
Innovative Diagnostic Methods for Early Prostate Cancer Detection through Urine Analysis: A Review.
Bax C, Taverna G, Eusebio L, Sironi S, Grizzi F, Guazzoni G
Cancers (Basel). 2018; 10(4).
PMID: 29670060
PMC: 5923378.
DOI: 10.3390/cancers10040123.
An overview of serum prostatic surface antigen cut points for recommendation of prostatic biopsy.
Patwardhan S, Patil B, Shelke U, Singh A
Urol Ann. 2018; 10(1):65-70.
PMID: 29416278
PMC: 5791460.
DOI: 10.4103/UA.UA_113_17.
Flexible modeling of the hazard rate and treatment effects in long-term survival studies.
Hagar Y, Dignam J, Dukic V
Stat Methods Med Res. 2017; 26(5):2455-2480.
PMID: 28150523
PMC: 5651995.
DOI: 10.1177/0962280216688034.
An Analytical Study of Prostate-Specific Antigen Dynamics.
Esteban E, Deliz G, Rivera-Rodriguez J, Laureano S
Comput Math Methods Med. 2016; 2016:3929163.
PMID: 27956935
PMC: 5124482.
DOI: 10.1155/2016/3929163.
Actual Contribution of Free to Total PSA Ratio in Prostate Diseases Differentiation.
Prcic A, Begic E, Hiros M
Med Arch. 2016; 70(4):288-292.
PMID: 27703291
PMC: 5034994.
DOI: 10.5455/medarh.2016.70.288-292.
An examination of clinical differences between carriers and non-carriers of chromosome 8q24 risk alleles in a New Zealand Caucasian population with prostate cancer.
Bishop K, Han D, Karunasinghe N, Goudie M, Masters J, Ferguson L
PeerJ. 2016; 4:e1731.
PMID: 26966665
PMC: 4782686.
DOI: 10.7717/peerj.1731.
Targeted prostate biopsy and MR-guided therapy for prostate cancer.
Woodrum D, Kawashima A, Gorny K, Mynderse L
Abdom Radiol (NY). 2016; 41(5):877-88.
PMID: 26907717
PMC: 5811219.
DOI: 10.1007/s00261-016-0681-3.
Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less.
Liu X, Tang J, Fei X, Li Q
Iran J Public Health. 2016; 44(11):1466-72.
PMID: 26744703
PMC: 4703225.
A Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside Potential.
Batra J, Girdhani S, Hlatky L
J Biomark. 2015; 2014:321680.
PMID: 26317031
PMC: 4437363.
DOI: 10.1155/2014/321680.